Your browser doesn't support javascript.
loading
A novel pulmonary fibrosis NOD/SCID murine model with natural aging.
Ma, Zhaoxia; Qiu, Lihua; Sun, Jianxiu; Wu, Zhen; Liang, Shu; Zhao, Yunhui; Yang, Jinmei; Yue, Shijun; Hu, Min; Li, Yanjiao.
Afiliación
  • Ma Z; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China.
  • Qiu L; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China.
  • Sun J; Yunnan Jici Institute for Regenerative Medicine Co., Ltd, Kunming, Yunnan, 650101, China.
  • Wu Z; Shenzhen Zhendejici Pharmaceutical Research and Development Co., Ltd, Shenzhen, 518048, Guangdong, China.
  • Liang S; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China.
  • Zhao Y; Yunnan Jici Institute for Regenerative Medicine Co., Ltd, Kunming, Yunnan, 650101, China.
  • Yang J; Yunnan Jici Institute for Regenerative Medicine Co., Ltd, Kunming, Yunnan, 650101, China.
  • Yue S; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China.
  • Hu M; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China. huminynkm@163.com.
  • Li Y; Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, Yunnan, 650214, China. YanjiaoLi1688@126.com.
BMC Pulm Med ; 24(1): 457, 2024 Sep 16.
Article en En | MEDLINE | ID: mdl-39285370
ABSTRACT

BACKGROUND:

Idiopathic pulmonary fibrosis (IPF) is an age-related disease severely affecting life quality with its prevalence rising as the population ages, yet there is still no effective treatment available. Cell therapy has emerged as a promising option for IPF, however, the absence of mature and stable animal models for IPF immunodeficiency hampers preclinical evaluations of human cell therapies, primarily due to rapid immune clearance of administered cells. This study aims to establish a reliable pulmonary fibrosis (PF) model in immunodeficient mice that supports autologous cell therapy and to investigate underlying mechanism.

METHODS:

We utilized thirty 5-week-old male NOD/SCID mice, categorizing them into three age groups 12weeks, 32 weeks and 43 weeks, with 6 mice euthanized randomly from each cohort for lung tissue analysis. We assessed fibrosis using HE staining, Masson's trichrome staining, α-SMA immunohistochemistry and hydroxyproline content measurement. Further, ß-galactosidase staining and gene expression analysis of MMP9, TGF-ß1, TNF-α, IL-1ß, IL-6, IL-8, SOD1, SOD2, NRF2, SIRT1, and SIRT3 were performed. ELISA was employed to quantify protein levels of TNF-α, TGF-ß1, and IL-8.

RESULTS:

When comparing lung tissues from 32-week-old and 43-week-old mice to those from 12-week-old mice, we noted a marked increase in inflammatory infiltration, fibrosis severity, and hydroxyproline content, alongside elevated expression levels of α-SMA and MMP9. Notably, the degree of fibrosis intensified with age. Additionally, ß-galactosidase staining became more pronounced in older mice. Quantitative PCR analyses revealed age-related, increases in the expression of senescence markers (GLB1, P16, P21), and proinflammatory genes (TGF-ß1, TNF-α, IL-1ß, IL-6, and IL-8). Conversely, the expression of anti-oxidative stress-related genes (SOD1, SOD2, NRF2, SIRT1, and SIRT3) declined, showing statistically significant differences (*P < 0.05, **P < 0.01, ***P < 0.001). ELISA results corroborated these findings, indicating a progressive rise in the protein levels of TGF-ß1, TNF-α, and IL-8 as the mice aged.

CONCLUSIONS:

The findings suggest that NOD/SCID mice aged 32 weeks and 43 weeks effectively model pulmonary fibrosis in an elderly context, with the disease pathogenesis likely driven by age-associated inflammation and oxidative stress.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Envejecimiento / Ratones SCID / Ratones Endogámicos NOD / Modelos Animales de Enfermedad / Sirtuina 1 Idioma: En Revista: BMC Pulm Med Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Envejecimiento / Ratones SCID / Ratones Endogámicos NOD / Modelos Animales de Enfermedad / Sirtuina 1 Idioma: En Revista: BMC Pulm Med Año: 2024 Tipo del documento: Article País de afiliación: China